Etoposide for the treatment of paediatric tumours: What is the best way to give it?
- 31 December 1996
- journal article
- review article
- Published by Elsevier in European Journal Of Cancer
- Vol. 32 (13) , 2291-2297
- https://doi.org/10.1016/s0959-8049(96)00301-2
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Exposure and schedule dependency of etoposide in neuroblastoma and leukaemia cells in vitroEuropean Journal Of Cancer, 1995
- Phase I and pharmacokinetic study of a water-soluble etoposide prodrug, etoposide phosphate (BMY-40481)European Journal Of Cancer, 1995
- Continuous infusion cyclosporin A to reverse etoposide resistance in pediatric tumoursAnti-Cancer Drugs, 1994
- 21-day schedule oral etoposide in children— a feasibility studyEuropean Journal Of Cancer, 1993
- Prospective study of etoposide scheduling in combination chemotherapy for limited disease small cell lung carcinomaEuropean Journal of Cancer and Clinical Oncology, 1991
- Modeling Interpatient Pharmacodynamic Variability of EtoposideJNCI Journal of the National Cancer Institute, 1991
- Bolus Versus Infusion Regimens of Etoposide and Cisplatin in Treatment of Non-Small Cell Lung Cancer: A Study of the North Central Cancer Treatment GroupJNCI Journal of the National Cancer Institute, 1990
- Clinical pharmacodynamics of continuous-infusion etoposideCancer Chemotherapy and Pharmacology, 1990
- Time-schedule dependency of the inhibiting activity of various anticancer drugs in the clonogenic assayCancer Chemotherapy and Pharmacology, 1985
- SCHEDULE DEPENDENCY OF THE ANTILEUKEMIC ACTIVITY OF THE PODOPHYLLOTOXIN‐DERIVATIVE VP 16–213 (NSC‐141540) IN L1210 LEUKEMIAActa Pathologica Microbiologica Scandinavica Section A Pathology, 1973